Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2021-09-14 15:41:24 UTC |
---|
HMDB ID | HMDB0001032 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Dehydroepiandrosterone sulfate |
---|
Description | Dehydroepiandrosterone sulfate or DHEA-S is the sulfated form of dehydroepiandrosterone (DHEA). This sulfation is reversibly catalyzed by sulfotransferase 2A1 (SULT2A1) primarily in the adrenals, the liver, and small intestine. In the blood, most DHEA is found as DHEA-S with levels that are about 300 times higher than those of free DHEA. Orally-ingested DHEA is converted into its sulfate when passing through the intestines and liver. Whereas DHEA levels naturally reach their peak in the early morning hours, DHEAS levels show no diurnal variation. From a practical point of view, measurement of DHEA-S is preferable to DHEA since levels are more stable. DHEA (from which DHEA-S comes from) is a natural steroid prohormone produced from cholesterol by the adrenal glands, the gonads, adipose tissue, brain, and in the skin (by an autocrine mechanism). DHEA is the precursor of androstenedione, which can undergo further conversion to produce the androgen testosterone and the estrogens estrone and estradiol. DHEA is also a potent sigma-1 agonist. Serum dehydroepiandrosterone sulfate is a classic marker for adrenarche, and subsequently for the individual hormonal milieu (PMID: 10599744 ). Dehydroepiandrosterone sulfate is an endogenously produced sex steroid that has been hypothesized to have anti-aging effects (PMID: 16960027 ). It also has been inversely associated with the development of atherosclerosis (PMID: 8956025 ). |
---|
Structure | [H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@H](CC[C@]12C)OS(O)(=O)=O InChI=1S/C19H28O5S/c1-18-9-7-13(24-25(21,22)23)11-12(18)3-4-14-15-5-6-17(20)19(15,2)10-8-16(14)18/h3,13-16H,4-11H2,1-2H3,(H,21,22,23)/t13-,14-,15-,16-,18-,19-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(3-beta)-3-(Sulfooxy)androst-5-en-17-one | ChEBI | 17-Ketoandrost-5-en-3beta-yl sulfate | ChEBI | 17-Oxoandrost-5-en-3beta-yl hydrogen sulphate | ChEBI | 3-O-Sulfodehydroepiandrosterone | ChEBI | 3beta-Hydroxyandrost-5-en-17-one 3-sulfate | ChEBI | Androst-5-en-17-on-3beta-yl sulfuric acid | ChEBI | Dehydroepiandrosterone 3-sulfate | ChEBI | Dehydroepiandrosterone monosulfate | ChEBI | Dehydroepiandrosterone sulphate | ChEBI | Dehydroisoandrosterone sulfate | ChEBI | Dehydroisoandrosterone-3-sulfate | ChEBI | DHEA sulfate | ChEBI | DHEA-S | ChEBI | DHEAS | ChEBI | Prasterone sulfate | ChEBI | (3-b)-3-(Sulfooxy)androst-5-en-17-one | Generator | (3-b)-3-(Sulphooxy)androst-5-en-17-one | Generator | (3-beta)-3-(Sulphooxy)androst-5-en-17-one | Generator | (3-Β)-3-(sulfooxy)androst-5-en-17-one | Generator | (3-Β)-3-(sulphooxy)androst-5-en-17-one | Generator | 17-Ketoandrost-5-en-3b-yl sulfate | Generator | 17-Ketoandrost-5-en-3b-yl sulfuric acid | Generator | 17-Ketoandrost-5-en-3b-yl sulphate | Generator | 17-Ketoandrost-5-en-3b-yl sulphuric acid | Generator | 17-Ketoandrost-5-en-3beta-yl sulfuric acid | Generator | 17-Ketoandrost-5-en-3beta-yl sulphate | Generator | 17-Ketoandrost-5-en-3beta-yl sulphuric acid | Generator | 17-Ketoandrost-5-en-3β-yl sulfate | Generator | 17-Ketoandrost-5-en-3β-yl sulfuric acid | Generator | 17-Ketoandrost-5-en-3β-yl sulphate | Generator | 17-Ketoandrost-5-en-3β-yl sulphuric acid | Generator | 17-Oxoandrost-5-en-3b-yl hydrogen sulfate | Generator | 17-Oxoandrost-5-en-3b-yl hydrogen sulfuric acid | Generator | 17-Oxoandrost-5-en-3b-yl hydrogen sulphate | Generator | 17-Oxoandrost-5-en-3b-yl hydrogen sulphuric acid | Generator | 17-Oxoandrost-5-en-3beta-yl hydrogen sulfate | Generator | 17-Oxoandrost-5-en-3beta-yl hydrogen sulfuric acid | Generator | 17-Oxoandrost-5-en-3beta-yl hydrogen sulphuric acid | Generator | 17-Oxoandrost-5-en-3β-yl hydrogen sulfate | Generator | 17-Oxoandrost-5-en-3β-yl hydrogen sulfuric acid | Generator | 17-Oxoandrost-5-en-3β-yl hydrogen sulphate | Generator | 17-Oxoandrost-5-en-3β-yl hydrogen sulphuric acid | Generator | 3-O-Sulphodehydroepiandrosterone | Generator | 3b-Hydroxyandrost-5-en-17-one 3-sulfate | Generator | 3b-Hydroxyandrost-5-en-17-one 3-sulfuric acid | Generator | 3b-Hydroxyandrost-5-en-17-one 3-sulphate | Generator | 3b-Hydroxyandrost-5-en-17-one 3-sulphuric acid | Generator | 3beta-Hydroxyandrost-5-en-17-one 3-sulfuric acid | Generator | 3beta-Hydroxyandrost-5-en-17-one 3-sulphate | Generator | 3beta-Hydroxyandrost-5-en-17-one 3-sulphuric acid | Generator | 3Β-hydroxyandrost-5-en-17-one 3-sulfate | Generator | 3Β-hydroxyandrost-5-en-17-one 3-sulfuric acid | Generator | 3Β-hydroxyandrost-5-en-17-one 3-sulphate | Generator | 3Β-hydroxyandrost-5-en-17-one 3-sulphuric acid | Generator | Androst-5-en-17-on-3b-yl sulfate | Generator | Androst-5-en-17-on-3b-yl sulfuric acid | Generator | Androst-5-en-17-on-3b-yl sulphate | Generator | Androst-5-en-17-on-3b-yl sulphuric acid | Generator | Androst-5-en-17-on-3beta-yl sulfate | Generator | Androst-5-en-17-on-3beta-yl sulphate | Generator | Androst-5-en-17-on-3beta-yl sulphuric acid | Generator | Androst-5-en-17-on-3β-yl sulfate | Generator | Androst-5-en-17-on-3β-yl sulfuric acid | Generator | Androst-5-en-17-on-3β-yl sulphate | Generator | Androst-5-en-17-on-3β-yl sulphuric acid | Generator | Dehydroepiandrosterone 3-sulfuric acid | Generator | Dehydroepiandrosterone 3-sulphate | Generator | Dehydroepiandrosterone 3-sulphuric acid | Generator | Dehydroepiandrosterone monosulfuric acid | Generator | Dehydroepiandrosterone monosulphate | Generator | Dehydroepiandrosterone monosulphuric acid | Generator | Dehydroepiandrosterone sulfuric acid | Generator | Dehydroepiandrosterone sulphuric acid | Generator | Dehydroisoandrosterone sulfuric acid | Generator | Dehydroisoandrosterone sulphate | Generator | Dehydroisoandrosterone sulphuric acid | Generator | Dehydroisoandrosterone-3-sulfuric acid | Generator | Dehydroisoandrosterone-3-sulphate | Generator | Dehydroisoandrosterone-3-sulphuric acid | Generator | DHEA sulfuric acid | Generator | DHEA sulphate | Generator | DHEA sulphuric acid | Generator | Prasterone sulfuric acid | Generator | Prasterone sulphate | Generator | Prasterone sulphuric acid | Generator | (3beta)-3-(Sulfooxy)-androst-5-en-17-one | HMDB | 17-Oxoandrost-5-en-3-yl hydrogen sulfate | HMDB | 17-Oxoandrost-5-en-3-yl hydrogen sulphate | HMDB | 3-b-Hydroxyandrost-5-en-17-one 3-sulfate | HMDB | 3-b-Hydroxyandrost-5-en-17-one 3-sulphate | HMDB | 3-beta-Hydroxyandrost-5-en-17-one 3-sulfate | HMDB | 3-beta-Hydroxyandrost-5-en-17-one 3-sulphate | HMDB | 3b-Hydroxy-androst-5-en-17-one hydrogen sulfate | HMDB | 3b-Hydroxy-androst-5-en-17-one hydrogen sulphate | HMDB | 3beta-Hydroxy-androst-5-en-17-one hydrogen sulfate | HMDB | 3beta-Hydroxy-androst-5-en-17-one hydrogen sulphate | HMDB | Dehydroepiandrosterone-3-sulfate | HMDB | Dehydroepiandrosterone-3-sulphate | HMDB | Formylisoglutamic acid | HMDB | Prasterone-3-sulfate | HMDB | Prasterone-3-sulphate | HMDB | DHA sulfate | HMDB | Sulfate, dehydroisoandrosterone | HMDB | Sulfate, prasterone | HMDB | Sulfate, dhea | HMDB | Sulfate, dehydroepiandrosterone | HMDB | Sulfate, dha | HMDB |
|
---|
Chemical Formula | C19H28O5S |
---|
Average Molecular Weight | 368.488 |
---|
Monoisotopic Molecular Weight | 368.165744696 |
---|
IUPAC Name | [(1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl]oxidanesulfonic acid |
---|
Traditional Name | [(1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl]oxidanesulfonic acid |
---|
CAS Registry Number | 651-48-9 |
---|
SMILES | [H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@H](CC[C@]12C)OS(O)(=O)=O |
---|
InChI Identifier | InChI=1S/C19H28O5S/c1-18-9-7-13(24-25(21,22)23)11-12(18)3-4-14-15-5-6-17(20)19(15,2)10-8-16(14)18/h3,13-16H,4-11H2,1-2H3,(H,21,22,23)/t13-,14-,15-,16-,18-,19-/m0/s1 |
---|
InChI Key | CZWCKYRVOZZJNM-USOAJAOKSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Sulfated steroids |
---|
Direct Parent | Sulfated steroids |
---|
Alternative Parents | |
---|
Substituents | - Sulfated steroid skeleton
- Androstane-skeleton
- 17-oxosteroid
- Oxosteroid
- Delta-5-steroid
- Sulfuric acid ester
- Alkyl sulfate
- Sulfuric acid monoester
- Sulfate-ester
- Organic sulfuric acid or derivatives
- Ketone
- Hydrocarbon derivative
- Organooxygen compound
- Organic oxygen compound
- Carbonyl group
- Organic oxide
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Dehydroepiandrosterone sulfate,1TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CCC2=O | 3118.3 | Semi standard non polar | 33892256 | Dehydroepiandrosterone sulfate,1TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CCC2=O | 3010.5 | Standard non polar | 33892256 | Dehydroepiandrosterone sulfate,1TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CCC2=O | 3791.2 | Standard polar | 33892256 | Dehydroepiandrosterone sulfate,1TMS,isomer #2 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C | 3095.6 | Semi standard non polar | 33892256 | Dehydroepiandrosterone sulfate,1TMS,isomer #2 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C | 2859.8 | Standard non polar | 33892256 | Dehydroepiandrosterone sulfate,1TMS,isomer #2 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C | 3817.0 | Standard polar | 33892256 | Dehydroepiandrosterone sulfate,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C | 3141.2 | Semi standard non polar | 33892256 | Dehydroepiandrosterone sulfate,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C | 3073.5 | Standard non polar | 33892256 | Dehydroepiandrosterone sulfate,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C | 3741.8 | Standard polar | 33892256 | Dehydroepiandrosterone sulfate,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OS(=O)(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]32)C1 | 3356.5 | Semi standard non polar | 33892256 | Dehydroepiandrosterone sulfate,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OS(=O)(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]32)C1 | 3326.6 | Standard non polar | 33892256 | Dehydroepiandrosterone sulfate,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OS(=O)(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]32)C1 | 3905.0 | Standard polar | 33892256 | Dehydroepiandrosterone sulfate,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C | 3357.9 | Semi standard non polar | 33892256 | Dehydroepiandrosterone sulfate,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C | 3123.0 | Standard non polar | 33892256 | Dehydroepiandrosterone sulfate,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C | 3966.8 | Standard polar | 33892256 | Dehydroepiandrosterone sulfate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3605.0 | Semi standard non polar | 33892256 | Dehydroepiandrosterone sulfate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3611.8 | Standard non polar | 33892256 | Dehydroepiandrosterone sulfate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3917.6 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Dehydroepiandrosterone sulfate GC-MS (Non-derivatized) - 70eV, Positive | splash10-002f-0097000000-e6d4f60e9803940d2f55 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dehydroepiandrosterone sulfate GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 10V, Negative-QTOF | splash10-014i-0009000000-d49a8b7164a230745f20 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 20V, Negative-QTOF | splash10-014i-3009000000-bd7e895ed74eba8a0f23 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 40V, Negative-QTOF | splash10-0002-9000000000-8d7ea5bd8a8a0d5219c7 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 30V, Negative-QTOF | splash10-0002-9001000000-5d89a4081c0f6b0c3324 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 10V, Positive-QTOF | splash10-014i-0049000000-f9a938b029283c157bdf | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 20V, Positive-QTOF | splash10-00di-0091000000-c2b83d86ae8174524e1d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 40V, Positive-QTOF | splash10-0udi-5792000000-20638b1484fe342eb3c9 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 10V, Negative-QTOF | splash10-014i-0029000000-79344bc1ba3ea2c26db7 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 20V, Negative-QTOF | splash10-00kr-1092000000-3b129a6c30b2629e1661 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 40V, Negative-QTOF | splash10-008i-6090000000-35cc2726715438281170 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 10V, Negative-QTOF | splash10-014i-0009000000-c58c9c29bacda1fca240 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 20V, Negative-QTOF | splash10-014i-1009000000-d5f9b663138c7975150b | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 40V, Negative-QTOF | splash10-0002-9105000000-a5c4a9d21c991c730dab | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 10V, Positive-QTOF | splash10-014i-0019000000-e7315ac14210f0dc3930 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 20V, Positive-QTOF | splash10-0uk9-0292000000-06a461930592bd575f19 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dehydroepiandrosterone sulfate 40V, Positive-QTOF | splash10-0a4m-4920000000-e6055497e2f92515f76a | 2021-09-23 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane
|
---|
Biospecimen Locations | |
---|
Tissue Locations | - Kidney
- Liver
- Placenta
- Prostate
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 3.47 +/- 1.20 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 28.9-40.7 uM | Newborn (0-30 days old) | Both | Normal | | details | Blood | Detected and Quantified | 0.81-16.28 uM | Infant (2 - <6 months old) | Both | Normal | | details | Blood | Detected and Quantified | 0.27-4.89 uM | Infant (6 months - <1 year old) | Both | Normal | | details | Blood | Detected and Quantified | 0-3.26 uM | Children (1 - <6 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.27-4.34 uM | Children (6 - <9 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.81-7.60 uM | Children (9 - <13 years old) | Both | Normal | | details | Blood | Detected and Quantified | 1.63-13.03 uM | Adolescent (13 - <16 years old) | Both | Normal | | details | Blood | Detected and Quantified | 4.07-16.01 uM | Adolescent (16 - <19 years old) | Female | Normal | | details | Blood | Detected and Quantified | 3.53-16.01 uM | Adolescent (16 - <19 years old) | Male | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | <0.500 uM | Not Specified | Both | Normal | | details | Blood | Detected and Quantified | 0.950-11.669 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 4.5 (1.4-8.2) uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.950 - 1.167 uM | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 1.25 (0.0026-2.52) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 1.34 +/- 0.23 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 42.0638-105.0238 uM | Newborn (0-30 days old) | Male | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | 3.63 +/- 2.14 uM | Adult (>18 years old) | Female | Polycystic ovary syndrome (PCOS) | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Lung cancer | | details | Blood | Detected and Quantified | 3.400-15 uM | Adult (>18 years old) | Male | X-linked ichthyosis | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Schizophrenia | | details | Blood | Detected and Quantified | 5.493 uM | Adult (>18 years old) | Female | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | 6.54 +/- 2.55 uM | Adult (>18 years old) | Female | Alzheimer's disease | | details | Blood | Detected and Quantified | 20 uM | Newborn (0-30 days old) | Female | 11-beta-hydroxylase deficiency | | details | Blood | Detected and Quantified | 2.000-10.400 uM | Children (1-13 years old) | Both | 11-beta-hydroxylase deficiency | | details | Blood | Detected and Quantified | <0.02 uM | Adult (>18 years old) | Female | Lipoid Adrenal Hyperplasia | | details | Blood | Detected and Quantified | <0.02 uM | Adolescent (13-18 years old) | Female | Lipoid Adrenal Hyperplasia | | details | Blood | Detected and Quantified | <0.810 uM | Children (1-13 years old) | Female | Aromatase deficiency | | details | Blood | Detected and Quantified | 0.0621 uM | Adult (>18 years old) | Female | Adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency | | details | Blood | Detected and Quantified | 0.104 uM | Adolescent (13-18 years old) | Female | Adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency | | details | Blood | Detected and Quantified | 9.8 +/- 1.3 uM | Adult (>18 years old) | Female | Hirsutism | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Epithelial ovarian cancer | | details | Urine | Detected and Quantified | 0.28 +/- 0.082 umol/mmol creatinine | Adult (>18 years old) | Both | Rheumatoid arthritis | | details | Urine | Detected and Quantified | 0.84 +/- 0.51 umol/mmol creatinine | Adult (>18 years old) | Both | Rheumatoid arthritis | | details | Urine | Detected and Quantified | 0.43 +/- 0.10 umol/mmol creatinine | Adult (>18 years old) | Both | Systemic lupus erythematosus (SLE) | | details | Urine | Detected and Quantified | 1.56 +/- 0.041 umol/mmol creatinine | Adult (>18 years old) | Both | Systemic lupus erythematosus (SLE) | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Polycystic ovary syndrome |
---|
- Yildiz BO, Woods KS, Stanczyk F, Bartolucci A, Azziz R: Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004 Nov;89(11):5558-62. [PubMed:15531511 ]
| Hirsutism |
---|
- Gilad S, Chayen R, Tordjman K, Kisch E, Stern N: Assessment of 5 alpha-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion. Clin Endocrinol (Oxf). 1994 Apr;40(4):459-64. [PubMed:8187312 ]
| Alzheimer's disease |
---|
- Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP, Campbell WS, Taylor PR: Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst. 1993 May 5;85(9):722-7. [PubMed:8478958 ]
| Lung Cancer |
---|
- Chen Y, Ma Z, Min L, Li H, Wang B, Zhong J, Dai L: Biomarker identification and pathway analysis by serum metabolomics of lung cancer. Biomed Res Int. 2015;2015:183624. doi: 10.1155/2015/183624. Epub 2015 Apr 16. [PubMed:25961003 ]
| Schizophrenia |
---|
- Bicikova M, Hill M, Ripova D, Mohr P, Hampl R: Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia. J Steroid Biochem Mol Biol. 2013 Jan;133:77-83. doi: 10.1016/j.jsbmb.2012.08.009. Epub 2012 Aug 24. [PubMed:22944140 ]
| Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency |
---|
- Hattori N, Ishihara T, Moridera K, Hino M, Ikekubo K, Kurahachi H: A case of late-onset congenital adrenal hyperplasia due to partial 3 beta-hydroxysteroid dehydrogenase deficiency. Endocr J. 1993 Feb;40(1):107-9. [PubMed:7951484 ]
- Guven A, Polat S: Testicular Adrenal Rest Tumor in Two Brothers with a Novel Mutation in the 3-Beta-Hydroxysteroid Dehydrogenase-2 Gene. J Clin Res Pediatr Endocrinol. 2017 Mar 1;9(1):85-90. doi: 10.4274/jcrpe.3306. Epub 2016 Jul 29. [PubMed:27476613 ]
| 11-beta-Hydroxylase deficiency |
---|
- Burren CP, Montalto J, Yong AB, Batch JA: CYP11 beta 1 (11-beta-hydroxylase) deficiency in congenital adrenal hyperplasia. J Paediatr Child Health. 1996 Oct;32(5):433-8. [PubMed:8933406 ]
| Aromatase deficiency |
---|
- Mullis PE, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P, Harada H: Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J Clin Endocrinol Metab. 1997 Jun;82(6):1739-45. doi: 10.1210/jcem.82.6.3994. [PubMed:9177373 ]
| Congenital Adrenal Hyperplasia, due to 17-Hydroxylase-Deficiency |
---|
- Kim SM, Rhee JH: A case of 17 alpha-hydroxylase deficiency. Clin Exp Reprod Med. 2015 Jun;42(2):72-6. doi: 10.5653/cerm.2015.42.2.72. Epub 2015 Jun 30. [PubMed:26161337 ]
| X-linked ichthyosis |
---|
- Lykkesfeldt G, Bennett P, Lykkesfeldt AE, Micic S, Moller S, Svenstrup B: Abnormal androgen and oestrogen metabolism in men with steroid sulphatase deficiency and recessive X-linked ichthyosis. Clin Endocrinol (Oxf). 1985 Oct;23(4):385-93. [PubMed:3864567 ]
| Lipoid Congenital Adrenal Hyperplasia |
---|
- Fujieda K, Tajima T, Nakae J, Sageshima S, Tachibana K, Suwa S, Sugawara T, Strauss JF 3rd: Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene. J Clin Invest. 1997 Mar 15;99(6):1265-71. doi: 10.1172/JCI119284. [PubMed:9077535 ]
| Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Rheumatoid arthritis |
---|
- Straub RH, Weidler C, Demmel B, Herrmann M, Kees F, Schmidt M, Scholmerich J, Schedel J: Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis. 2004 Aug;63(8):961-8. [PubMed:15249323 ]
|
|
---|
Associated OMIM IDs | - 184700 (Polycystic ovary syndrome)
- 104300 (Alzheimer's disease)
- 211980 (Lung Cancer)
- 181500 (Schizophrenia)
- 201810 (Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency)
- 202010 (11-beta-Hydroxylase deficiency)
- 613546 (Aromatase deficiency)
- 202110 (Congenital Adrenal Hyperplasia, due to 17-Hydroxylase-Deficiency)
- 308100 (X-linked ichthyosis)
- 201710 (Lipoid Congenital Adrenal Hyperplasia)
- 114500 (Colorectal cancer)
- 180300 (Rheumatoid arthritis)
|
---|
External Links |
---|
DrugBank ID | DB05804 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022381 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 12074 |
---|
KEGG Compound ID | C04555 |
---|
BioCyc ID | DEHYDRO-EPIANDROSTERONE-SULFATE |
---|
BiGG ID | 44038 |
---|
Wikipedia Link | Dehydroepiandrosterone_sulfate |
---|
METLIN ID | 4095 |
---|
PubChem Compound | 12594 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 16814 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | DHEAS |
---|
MarkerDB ID | MDB00000294 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Chang HJ, Shi R, Rehse P, Lin SX: Identifying androsterone (ADT) as a cognate substrate for human dehydroepiandrosterone sulfotransferase (DHEA-ST) important for steroid homeostasis: structure of the enzyme-ADT complex. J Biol Chem. 2004 Jan 23;279(4):2689-96. Epub 2003 Oct 21. [PubMed:14573603 ]
- Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762. [PubMed:19212411 ]
- Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Pizzorni C, Paolino S, Seriolo B, Felli L, Straub RH: Anti-TNF and sex hormones. Ann N Y Acad Sci. 2006 Jun;1069:391-400. [PubMed:16855166 ]
- Clauss SB, Holmes KW, Hopkins P, Stein E, Cho M, Tate A, Johnson-Levonas AO, Kwiterovich PO: Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia. Pediatrics. 2005 Sep;116(3):682-8. [PubMed:16140708 ]
- Gordon GB, Bush TL, Helzlsouer KJ, Miller SR, Comstock GW: Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res. 1990 Jul 1;50(13):3859-62. [PubMed:2141293 ]
- Roberts E: The importance of being dehydroepiandrosterone sulfate (in the blood of primates): a longer and healthier life? Biochem Pharmacol. 1999 Feb 15;57(4):329-46. [PubMed:9933021 ]
- Gu H, Li Y, Rong L: [The effect of sodium prasterone sulfate on lactation]. Zhonghua Fu Chan Ke Za Zhi. 1995 Apr;30(4):197-9. [PubMed:7664601 ]
- Milewich L, Sontheimer RD, Herndon JH Jr: Steroid sulfatase activity in epidermis of acne-prone and non-acne-prone skin of patients with acne vulgaris. Arch Dermatol. 1990 Oct;126(10):1312-4. [PubMed:2145810 ]
- Dalla Valle L, Toffolo V, Nardi A, Fiore C, Bernante P, Di Liddo R, Parnigotto PP, Colombo L: Tissue-specific transcriptional initiation and activity of steroid sulfatase complementing dehydroepiandrosterone sulfate uptake and intracrine steroid activations in human adipose tissue. J Endocrinol. 2006 Jul;190(1):129-39. [PubMed:16837617 ]
- Zappulla F, Ventura D, Capelli M, Cassio A, Balsamo A, Frejaville E, Bolelli G, Cacciari E: Gonadal and adrenal secretion of dehydroepiandrosterone sulfate in prepubertal and pubertal subjects. J Endocrinol Invest. 1981 Apr-Jun;4(2):197-202. [PubMed:6268694 ]
- Ankarberg C, Norjavaara E: Diurnal rhythm of testosterone secretion before and throughout puberty in healthy girls: correlation with 17beta-estradiol and dehydroepiandrosterone sulfate. J Clin Endocrinol Metab. 1999 Mar;84(3):975-84. [PubMed:10084582 ]
- Sipila S, Heikkinen E, Cheng S, Suominen H, Saari P, Kovanen V, Alen M, Rantanen T: Endogenous hormones, muscle strength, and risk of fall-related fractures in older women. J Gerontol A Biol Sci Med Sci. 2006 Jan;61(1):92-6. [PubMed:16456199 ]
- Benvenga S, Smedile G, Lo Giudice F, Trimarchi F: Testicular adrenal rests: evidence for luteinizing hormone receptors and for distinct types of testicular nodules differing for their autonomization. Eur J Endocrinol. 1999 Sep;141(3):231-7. [PubMed:10474120 ]
- Rainey WE, Rehman KS, Carr BR: The human fetal adrenal: making adrenal androgens for placental estrogens. Semin Reprod Med. 2004 Nov;22(4):327-36. [PubMed:15635500 ]
- Zouboulis CC, Degitz K: Androgen action on human skin -- from basic research to clinical significance. Exp Dermatol. 2004;13 Suppl 4:5-10. [PubMed:15507105 ]
- De Pergola G, Zamboni M, Sciaraffia M, Turcato E, Pannacciulli N, Armellini F, Giorgino F, Perrini S, Bosello O, Giorgino R: Body fat accumulation is possibly responsible for lower dehydroepiandrosterone circulating levels in premenopausal obese women. Int J Obes Relat Metab Disord. 1996 Dec;20(12):1105-10. [PubMed:8968856 ]
- Coulter CL, Jaffe RB: Functional maturation of the primate fetal adrenal in vivo: 3. Specific zonal localization and developmental regulation of CYP21A2 (P450c21) and CYP11B1/CYP11B2 (P450c11/aldosterone synthase) lead to integrated concept of zonal and temporal steroid biosynthesis. Endocrinology. 1998 Dec;139(12):5144-50. [PubMed:9832454 ]
- Wang HS, Wang TH, Soong YK: Low dose flutamide in the treatment of acne vulgaris in women with or without oligomenorrhea or amenorrhea. Changgeng Yi Xue Za Zhi. 1999 Sep;22(3):423-32. [PubMed:10584414 ]
- Ibanez L, Potau N, Marcos MV, de Zegher F: Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J Clin Endocrinol Metab. 1999 Dec;84(12):4739-41. [PubMed:10599744 ]
- Cappola AR, Xue QL, Walston JD, Leng SX, Ferrucci L, Guralnik J, Fried LP: DHEAS levels and mortality in disabled older women: the Women's Health and Aging Study I. J Gerontol A Biol Sci Med Sci. 2006 Sep;61(9):957-62. [PubMed:16960027 ]
- Jaquish CE, Blangero J, Haffner SM, Stern MP, Maccluer JW: Quantitative genetics of dehydroepiandrosterone sulfate and its relation to possible cardiovascular disease risk factors in Mexican Americans. Hum Hered. 1996 Nov-Dec;46(6):301-9. [PubMed:8956025 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
---|